SCHEMBL10296137

SCHEMBL10296137

CCC(NC)C(=O)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19245403 1.00
SCHEMBL15834073 1.00
Hydrochloric Acid SCHEMBL28241322 0.97 USP2 (0.36)
SCHEMBL10296126 0.80 USP2 (0.34)
SCHEMBL25719293 0.80 HDAC7 (0.43)
SCHEMBL13227770 0.80 HDAC7 (0.43)
SCHEMBL19993047 0.79
SCHEMBL15765660 0.79
SCHEMBL14588571 0.78 ALDH1A1 (0.38)
SCHEMBL15159359 0.78 KDM4E (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed
US-20210198203-A1 COMPOUNDS, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED 2021-07-01 US disclosed
WO-2020029980-A1 SMAD3 INHIBITORS MOEXA PHARMACEUTICALS LIMITED (CN) 2020-02-13 WO disclosed
US-8828433-B2 Hydrogel bioscaffoldings and biomedical device coatings ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2014-09-09 US disclosed
US-8513257-B2 Ureas and their use in the treatment of heart failure CYTOKINETICS, INCORPORATED (US) 2013-08-20 US disclosed
EP-2471363-A1 Use of aryl-, heteroaryl- and benzylsulfonamide carboxylic acids, -carboxylic acid esters, -carboxylic acid amides and -carbonitriles and/or its salts for increasing stress tolerance in plants Bayer CropScience AG (DE) 2012-07-04 EP disclosed